EMEA accepts prasterone MAA

The EMEA accepted for filing an MAA from Genelabs (GNLB) for Anastar prasterone ( Prestara in the U.S.) to treat systemic lupus erythematosus (SLE) and/or reduce glucocorticoid use in women. GNLB said...